SenesTech (SNES) IPO Opens Modestly Higher

Today's IPO for SenesTech, Inc. (Nasdaq: SNES) opened for trading at $8.25 after pricing its initial public offering of 1,875,000 shares of common stock priced at $8.00 per share. The company was recently looking to offer 2 million shares and saw a pricing range of $9 - $11 per share.)

Roth Capital Partners is acting as sole book-running manager, and Craig-Hallum Capital Group and Aegis Capital Corp. are acting as co-managers.

SenesTech has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product candidate, ContraPest®, will be marketed for use initially in controlling rat infestations. We believe our non-lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. There is currently no fertility control product approved by the Food and Drug Administration (FDA), or the Environmental Protection Agency (EPA), for the management of rodent populations. We believe ContraPest® will establish a new paradigm in rodent control, resulting in improved performance in rodent control over rodenticides, without the negative environmental effects of rodenticides.

You May Also Be Interested In

• SpaceX blocks China and Hong Kong investors from $75 billion IPO
• Trump administration and OpenAI discuss potential U.S. equity stake, CNBC reports
• Quantinuum closes $1.68 billion IPO at $60 per share